Paul R Michl

Array ( [id] => 4380984 [patent_doc_number] => 06303661 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals' [patent_app_type] => 1 [patent_app_number] => 9/155833 [patent_app_country] => US [patent_app_date] => 1998-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 3372 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303661.pdf [firstpage_image] =>[orig_patent_app_number] => 155833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359958 [patent_doc_number] => 06169072 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'Cyclic adhesion inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/164585 [patent_app_country] => US [patent_app_date] => 1998-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6830 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/169/06169072.pdf [firstpage_image] =>[orig_patent_app_number] => 164585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4257803 [patent_doc_number] => 06258597 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Stimulation of hematopoietic cells in vitro' [patent_app_type] => 1 [patent_app_number] => 9/162934 [patent_app_country] => US [patent_app_date] => 1998-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 16994 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258597.pdf [firstpage_image] =>[orig_patent_app_number] => 162934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359301 [patent_doc_number] => 06191114 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Immunological activity for a peptide of the limulus anti-LPS factor' [patent_app_type] => 1 [patent_app_number] => 9/160309 [patent_app_country] => US [patent_app_date] => 1998-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 8566 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/191/06191114.pdf [firstpage_image] =>[orig_patent_app_number] => 160309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4184132 [patent_doc_number] => 06150345 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Methods for promoting survival of myelin producing cells' [patent_app_type] => 1 [patent_app_number] => 9/153464 [patent_app_country] => US [patent_app_date] => 1998-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6521 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150345.pdf [firstpage_image] =>[orig_patent_app_number] => 153464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407349 [patent_doc_number] => 06172042 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Synthetic peptides that inhibit IL-6 activity' [patent_app_type] => 1 [patent_app_number] => 9/043785 [patent_app_country] => US [patent_app_date] => 1998-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6969 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/172/06172042.pdf [firstpage_image] =>[orig_patent_app_number] => 043785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410288 [patent_doc_number] => 06310093 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Method of preventing neuronal death' [patent_app_type] => 1 [patent_app_number] => 9/141881 [patent_app_country] => US [patent_app_date] => 1998-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 15662 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310093.pdf [firstpage_image] =>[orig_patent_app_number] => 141881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4296659 [patent_doc_number] => 06251396 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein' [patent_app_type] => 1 [patent_app_number] => 9/137759 [patent_app_country] => US [patent_app_date] => 1998-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 28 [patent_no_of_words] => 14920 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251396.pdf [firstpage_image] =>[orig_patent_app_number] => 137759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4411492 [patent_doc_number] => 06265534 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Superpotent calcitonin analogs having greatly increased hypocalcemic action in vivo' [patent_app_type] => 1 [patent_app_number] => 9/137389 [patent_app_country] => US [patent_app_date] => 1998-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3105 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265534.pdf [firstpage_image] =>[orig_patent_app_number] => 137389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1371207 [patent_doc_number] => 06566491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-20 [patent_title] => 'Cyclopeptide derivatives' [patent_app_type] => B2 [patent_app_number] => 09/051603 [patent_app_country] => US [patent_app_date] => 1998-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15800 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 293 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566491.pdf [firstpage_image] =>[orig_patent_app_number] => 09051603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 345123 [patent_doc_number] => 07498310 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-03-03 [patent_title] => 'Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation' [patent_app_type] => utility [patent_app_number] => 09/132799 [patent_app_country] => US [patent_app_date] => 1998-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8690 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/498/07498310.pdf [firstpage_image] =>[orig_patent_app_number] => 09132799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4377093 [patent_doc_number] => 06294170 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Composition and method for treating inflammatory diseases' [patent_app_type] => 1 [patent_app_number] => 9/131247 [patent_app_country] => US [patent_app_date] => 1998-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32979 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294170.pdf [firstpage_image] =>[orig_patent_app_number] => 131247 [rel_patent_id] =>[rel_patent_doc_number] =>)